About
Proteomics International is a medical technology company based in Perth, Western Australia, founded in 2001. It specializes in proteomics, focusing on the study of proteins to enhance healthcare outcomes. The company is dedicated to developing innovative diagnostic tools for chronic diseases and operates from advanced facilities at the Harry Perkins Institute of Medical Research. The company offers a range of proprietary diagnostic tests, including PromarkerD for diabetic kidney disease, PromarkerEndo for endometriosis, and PromarkerEso for esophageal cancer, all recognized for their accuracy and clinical significance. Additionally, Proteomics International provides specialist accredited analytical services, including pharmacokinetic testing and biomarker services, supporting the biotech and pharmaceutical industries. Its laboratory is ISO/IEC 17025:2005 accredited, ensuring high-quality results. The company also engages in research and development, continually working on new tests to address unmet medical needs.
Technologies
Keywords
Company Information
-
Employees 38
-
Founded 2001
-
Annual Revenue $627000
-
Total Funding $1400000
Location
6 Verdun St, Perth, Western Australia, Australia, 6009
